花旗-恒瑞医药(1276.HK):长期管线深厚,短期新药销售起飞-Jiangsu Hengrui Pharmaceuticals(1276.HK):Deepest pipeline for long term;new drug sales taking off for near term-20260112【14页】

发表回复

后才能评论